vs
Side-by-side financial comparison of Cronos Group Inc. (CRON) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.
Repay Holdings Corp is the larger business by last-quarter revenue ($78.6M vs $44.5M, roughly 1.8× Cronos Group Inc.). Cronos Group Inc. runs the higher net margin — -4.1% vs -178.3%, a 174.2% gap on every dollar of revenue. On growth, Cronos Group Inc. posted the faster year-over-year revenue change (47.0% vs 0.4%). Repay Holdings Corp produced more free cash flow last quarter ($23.2M vs $9.7M). Over the past eight quarters, Cronos Group Inc.'s revenue compounded faster (32.7% CAGR vs -1.3%).
Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
CRON vs RPAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.5M | $78.6M |
| Net Profit | $-1.8M | $-140.1M |
| Gross Margin | 36.4% | 74.2% |
| Operating Margin | -16.8% | -182.2% |
| Net Margin | -4.1% | -178.3% |
| Revenue YoY | 47.0% | 0.4% |
| Net Profit YoY | -104.2% | -3304.1% |
| EPS (diluted) | $-0.01 | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.5M | $78.6M | ||
| Q3 25 | $36.3M | $77.7M | ||
| Q2 25 | $33.5M | $75.6M | ||
| Q1 25 | $32.3M | $77.3M | ||
| Q4 24 | $30.3M | $78.3M | ||
| Q3 24 | $34.3M | $79.1M | ||
| Q2 24 | $27.8M | $74.9M | ||
| Q1 24 | $25.3M | $80.7M |
| Q4 25 | $-1.8M | $-140.1M | ||
| Q3 25 | $26.0M | $-6.4M | ||
| Q2 25 | $-39.7M | $-102.3M | ||
| Q1 25 | $6.1M | $-7.9M | ||
| Q4 24 | $43.7M | $-4.1M | ||
| Q3 24 | $8.3M | $3.2M | ||
| Q2 24 | $-8.8M | $-4.1M | ||
| Q1 24 | $-2.2M | $-5.2M |
| Q4 25 | 36.4% | 74.2% | ||
| Q3 25 | 50.4% | 74.4% | ||
| Q2 25 | 43.4% | 75.7% | ||
| Q1 25 | 42.6% | 75.9% | ||
| Q4 24 | 35.7% | 76.3% | ||
| Q3 24 | 10.5% | 77.8% | ||
| Q2 24 | 22.7% | 78.2% | ||
| Q1 24 | 17.7% | 76.2% |
| Q4 25 | -16.8% | -182.2% | ||
| Q3 25 | -1.4% | -3.9% | ||
| Q2 25 | -15.9% | -138.7% | ||
| Q1 25 | -12.6% | -4.7% | ||
| Q4 24 | -37.5% | -1.5% | ||
| Q3 24 | -98.2% | -0.9% | ||
| Q2 24 | -56.1% | -4.6% | ||
| Q1 24 | -63.1% | -3.1% |
| Q4 25 | -4.1% | -178.3% | ||
| Q3 25 | 71.4% | -8.3% | ||
| Q2 25 | -118.7% | -135.2% | ||
| Q1 25 | 19.0% | -10.3% | ||
| Q4 24 | 144.3% | -5.3% | ||
| Q3 24 | 24.4% | 4.1% | ||
| Q2 24 | -31.5% | -5.4% | ||
| Q1 24 | -8.9% | -6.5% |
| Q4 25 | $-0.01 | $-1.68 | ||
| Q3 25 | $0.07 | $-0.08 | ||
| Q2 25 | $-0.10 | $-1.15 | ||
| Q1 25 | $0.02 | $-0.09 | ||
| Q4 24 | $0.12 | $-0.04 | ||
| Q3 24 | $0.02 | $0.03 | ||
| Q2 24 | $-0.02 | $-0.04 | ||
| Q1 24 | $-0.01 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $831.8M | $115.7M |
| Total DebtLower is stronger | — | $280.1M |
| Stockholders' EquityBook value | $1.1B | $484.4M |
| Total Assets | $1.2B | $1.2B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $831.8M | $115.7M | ||
| Q3 25 | $824.2M | $95.7M | ||
| Q2 25 | $834.4M | $162.6M | ||
| Q1 25 | $837.8M | $165.5M | ||
| Q4 24 | $858.8M | $189.5M | ||
| Q3 24 | $862.0M | $168.7M | ||
| Q2 24 | $848.2M | $147.1M | ||
| Q1 24 | $855.1M | $128.3M |
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
| Q4 25 | $1.1B | $484.4M | ||
| Q3 25 | $1.1B | $616.9M | ||
| Q2 25 | $1.1B | $633.7M | ||
| Q1 25 | $1.1B | $755.7M | ||
| Q4 24 | $1.1B | $761.3M | ||
| Q3 24 | $1.1B | $754.7M | ||
| Q2 24 | $1.1B | $815.4M | ||
| Q1 24 | $1.1B | $813.8M |
| Q4 25 | $1.2B | $1.2B | ||
| Q3 25 | $1.2B | $1.3B | ||
| Q2 25 | $1.2B | $1.4B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | $1.2B | $1.6B | ||
| Q3 24 | $1.2B | $1.6B | ||
| Q2 24 | $1.1B | $1.5B | ||
| Q1 24 | $1.1B | $1.5B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.8M | $23.3M |
| Free Cash FlowOCF − Capex | $9.7M | $23.2M |
| FCF MarginFCF / Revenue | 21.8% | 29.6% |
| Capex IntensityCapex / Revenue | 4.8% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $149.0K | $90.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.8M | $23.3M | ||
| Q3 25 | $13.3M | $32.2M | ||
| Q2 25 | $2.8M | $33.1M | ||
| Q1 25 | $-2.1M | $2.5M | ||
| Q4 24 | $7.7M | $34.3M | ||
| Q3 24 | $11.6M | $60.1M | ||
| Q2 24 | $1.7M | $31.0M | ||
| Q1 24 | $-2.2M | $24.8M |
| Q4 25 | $9.7M | $23.2M | ||
| Q3 25 | $8.8M | $32.1M | ||
| Q2 25 | $-1.0M | $33.0M | ||
| Q1 25 | $-17.4M | $2.4M | ||
| Q4 24 | $4.2M | $34.0M | ||
| Q3 24 | $5.2M | $59.8M | ||
| Q2 24 | $1.0M | $30.5M | ||
| Q1 24 | $-3.9M | $24.7M |
| Q4 25 | 21.8% | 29.6% | ||
| Q3 25 | 24.3% | 41.3% | ||
| Q2 25 | -3.0% | 43.6% | ||
| Q1 25 | -53.8% | 3.0% | ||
| Q4 24 | 13.8% | 43.5% | ||
| Q3 24 | 15.1% | 75.6% | ||
| Q2 24 | 3.7% | 40.7% | ||
| Q1 24 | -15.5% | 30.6% |
| Q4 25 | 4.8% | 0.1% | ||
| Q3 25 | 12.3% | 0.2% | ||
| Q2 25 | 11.5% | 0.1% | ||
| Q1 25 | 47.3% | 0.2% | ||
| Q4 24 | 11.7% | 0.3% | ||
| Q3 24 | 18.7% | 0.3% | ||
| Q2 24 | 2.6% | 0.6% | ||
| Q1 24 | 6.8% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.34× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 1.39× | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
